1.
Prima Sanjiwani Saraswati Sudarsa, Mario Korwa, Nyoman Suryawati. Therapeutic Outcomes of Secukinumab 300 mg in Severe Psoriasis Vulgaris with Metabolic Comorbidities: A Retrospective Cohort Study in Bali. Bioscmed. 2026;10(4):1048-1096. doi:10.37275/bsm.v10i4.1552